Neuropsychiatric Toxicity of Ifosfamide in Patients Admitted for Chemotherapy
Introduction: Ifosfamide (IFO) is a potent drug that is used in cancer therapy. The major uses of IFO are: solid tumors especially, osteogenic sarcoma, other soft tissue sarcomas and hematologic malignancy, especially in lymphoma patients. The toxicity of IFO is very encompassing and includes: alope...
Main Authors: | Mohammadali Mashhadi, Alireza Khosravi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2010-03-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/236 |
Similar Items
-
Neuropsychiatric Toxicity of Ifosfamide in Patients Admitted for Chemotherapy
by: Mohammadali Mashhadi, et al.
Published: (2010-01-01) -
Ifosfamide-induced extrapyramidal neurotoxicity with COVID-19
by: Chitrakshi Nagpal, et al.
Published: (2023-01-01) -
Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients
by: Moritz Schmidt, et al.
Published: (2022-09-01) -
Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney
by: Hyoung-Yun Han, et al.
Published: (2021-11-01) -
Induced resistance to ifosfamide in osteosarcoma cells suggests a more aggressive tumor profile
by: Maria Tereza de Oliveira Rodrigues, et al.
Published: (2022-12-01)